Revisión | 2025 |
Brain reserve in hepatic encephalopathy: Pathways of damage and preventive strategies through lifestyle and therapeutic interventions
|
ANNALS OF HEPATOLOGY |
Letter | 2025 |
Letter to the Editor: Serum Identification of At-Risk MASH: The Metabolomics-Advanced Steatohepatitis Fibrosis Score (MASEF)
|
HEPATOLOGY |
Artículo | 2025 |
Loss of Cdkn1a protects against MASLD alone or with alcohol intake by preserving lipid homeostasis
|
JHEP Reports |
Artículo | 2025 |
Portal hypertension: recommendations for diagnosis and treatment. Consensus document sponsored by the Spanish Association for the Study of the Liver (AEEH) and the Biomedical Research Network Centre for Liver and Digestive Diseases (CIBERehd)
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Artículo | 2024 |
Ammonia-induced stress response in liver disease progression and hepatic encephalopathy.
|
Nature Reviews Gastroenterology and Hepatology |
Artículo | 2024 |
Biomarcadores en MASLD, ¿estamos ante una nueva era?
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Revisión | 2024 |
Circular RNAs in non-alcoholic fatty liver disease: Functions and clinical significance
|
RNA BIOLOGY |
Artículo | 2024 |
Crohn´s disease is an independent risk factor for liver fibrosis in patients with inflammatory bowel disease and non-alcoholic fatty liver disease
|
EUROPEAN JOURNAL OF INTERNAL MEDICINE |
Artículo | 2024 |
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis
|
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
Resumen congreso | 2024 |
Differential transcriptomic profile in platelet-derived extracellular vesicles in patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2024 |
Dysregulation of ureagenesis and glutaminolysis in DIAMONDTM mice played a major role in MASLD progression
|
JOURNAL OF HEPATOLOGY |
Artículo | 2024 |
FIB-4 score as predictor of COVID-19-related severity in hospitalized patients.
|
Revista Española de Enfermedades Digestivas |
Artículo | 2024 |
Fibroblast growth factor 21 is a hepatokine involved in MASLD progression
|
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL |
Artículo | 2024 |
Longitudinal outcomes of obeticholic acid therapy in ursodiol-nonresponsive primary biliary cholangitis: Stratifying the impact of add-on fibrates in real-world practice
|
ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
Artículo | 2024 |
Low penetrance of frequent ATP7B mutations explains the low prevalence of Wilson disease. Lessons from real-life registries.
|
DIGESTIVE AND LIVER DISEASE |
Revisión | 2024 |
Novel insights into metabolic-associated steatotic liver disease preclinical models
|
LIVER INTERNATIONAL |
Artículo | 2024 |
One-step non-invasive diagnosis of metabolic dysfunction-associated steatohepatitis and fibrosis in high-risk population
|
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL |
Resumen congreso | 2024 |
Paediatric solid organ transplant recipients (SOTR) demonstrate greater serological response to initial SARS-CoV-2 vaccination than adult SOTR, and comparable rates of antibody degradation
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2024 |
Platelet-derived extracellular vesicles (PEVs) as a potential biomarker for hepatocellular carcinoma (HCC)
|
JOURNAL OF HEPATOLOGY |
Artículo | 2024 |
Predictive factors for decompensating events in cirrhotic patients with primary biliary cholangitis under different lines of therapy
|
HEPATOLOGY |
Short Survey | 2024 |
Proceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH)
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Artículo | 2024 |
Rituximab is a safe and effective alternative treatment for patients with autoimmune hepatitis: results from the ColHai registry
|
LIVER INTERNATIONAL |
Artículo | 2024 |
Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease
|
GUT |
Artículo | 2024 |
Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF)
|
HEPATOLOGY |
Artículo | 2024 |
The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis
|
Journal of Gastroenterology |
Artículo | 2024 |
Three double-dose reinforced hepatitis B revaccination scheme for patients with cirrhosis unresponsive to the standard regimen: an open-label randomised clinical trial
|
GUT |
Resumen congreso | 2024 |
Transaminase Pattern Over Time Is Not Associated with a More Aggressive Hepatic Evolution: Results from the AEEH Wilson Registry
|
JOURNAL OF HEPATOLOGY |
Letter | 2023 |
A second update on mapping the human genetic architecture of COVID-19.
|
NATURE |
Artículo | 2023 |
AEEH «Consensus about detection and referral of hidden prevalent liver diseases»
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Artículo | 2023 |
An individual patient data meta-analysis to determine cut-offs for and confounders of NAFLD-fibrosis staging with magnetic resonance elastography.
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2023 |
Analysis of the diagnostic accuracy of the non-invasive fibrosis indices NFS, HFS, and FIB-4 in the staging of advanced fibrosis in patients with metabolic fatty liver: meta-analysis of comparative studies
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2023 |
At- risk nash identification using an algorithm that combines fib-4+masef ( metabolomicsadvanced steatohepatitis fibrosis score)
|
HEPATOLOGY |
Resumen congreso | 2023 |
Biomarkers of endothelial dysfunction in patients with nonalcoholic fatty liver disease (NAFLD)
|
JOURNAL OF HEPATOLOGY |
Artículo | 2023 |
Circulating bone morphogenetic protein 8A is a novel biomarker to predict advanced liver fibrosis.
|
Biomarker Research |
Revisión | 2023 |
Clinical application of Magnetic resonance elastography in hepatocellular carcinoma: From diagnosis to prognosis
|
ANNALS OF HEPATOLOGY |
Corrección | 2023 |
Corrigendum to “Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosis” (Journal of Hepatology (2023) 79(4) (967–976), (S0168827823003513), (10.1016/j.jhep.2023.05.022))
|
JOURNAL OF HEPATOLOGY |
Artículo | 2023 |
Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosis
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2023 |
Development and validation of the AMMON-OHE model to risk stratify cirrhotic outpatients for ocurrence of overt hepatic encephalopathy
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2023 |
EFFECTIVENESS AND SAFETY OF SECOND-LINE THERAPY IN PRIMARY BILIARY CHOLANGITIS (PBC): A PROSPECTIVE MULTICENTER REAL-WORLD COHORT
|
HEPATOLOGY |
Resumen congreso | 2023 |
Endothelial and platelet-derived microvesicles as a biomarker of cardiovascular risk in patients with metabolic dysfunction-associated fatty liver disease (MAFLD)
|
JOURNAL OF HEPATOLOGY |
Revisión | 2023 |
Enfermedad de Wilson
|
MEDICINA CLINICA |
Resumen congreso | 2023 |
First nationwide genetic study on Wilson disease (Spanish Wilson registry): high diversity in mutations and in use of genetic evaluation, association with clinical data and influence on diagnosis and health costs
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2023 |
Glutaminolysis and Steatosis to Steatohepatitis Transition: Role of Glutaminase
|
AMERICAN JOURNAL OF GASTROENTEROLOGY |
Resumen congreso | 2023 |
HISTOLOGICAL CLASSIFICATIONS AND PREDICTION OF LIVER- RELATED EVENTS : RESULTS FROM THE MULTICENTRIC, EUROPEAN, HEPATIC OUTCOMES AND SURVIVAL FATTY LIVER REGISTRY ( HOTSURFR) STUDY
|
HEPATOLOGY |
Resumen congreso | 2023 |
Histological classifications versus liver-related events: results from the multicentric, European, hepatic outcomes and survival fatty liver registry (HOTSURFR) study
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2023 |
Identification of new serological biomarkers for the detection of significant fibrosis
|
HEPATOLOGY |
Resumen congreso | 2023 |
Impact of obesity on transient elastography accuracy among patients with non-alcoholic fatty liver disease
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2023 |
Impact of the metabolic profile on the response to ursodeoxycholic acid in patients with primary biliary cholangitis: results of the ColHai registry
|
JOURNAL OF HEPATOLOGY |
Artículo | 2023 |
Impacto de la enseñanza integrada de la patología médico-quirúrgica en pequeños grupos basada en la resolución de problemas en el aprendizaje de la medicina
|
Innova medica: revista de innovación docente de la Facultad de Medicina de Sevilla |
Artículo | 2023 |
Inflammatory Bowel Disease Is an Independent Risk Factor for Metabolic Dysfunction-Associated Steatotic Liver Disease in Lean Individuals
|
INFLAMMATORY BOWEL DISEASES |
Resumen congreso | 2023 |
Lessons from population genomics for Wilson disease: Prevalence, penetrance of mutations, clinical implications and design of regional screening programmes
|
JOURNAL OF HEPATOLOGY |
Artículo | 2023 |
Liver cancer stem cell dissemination and metastasis: uncovering the role of NRCAM in hepatocellular carcinoma
|
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH |
Artículo | 2023 |
Liver stiffness accuracy by MR elastography in histologically proven non-alcoholic fatty liver disease patients: a Spanish cohort
|
Revista Española de Enfermedades Digestivas |
Resumen congreso | 2023 |
Long-term prospective follow-up of a primary biliary cholangitis (PBC) multicenter cohort treated with Obeticholic Acid (OCA). Interaction effect of triple therapy with fibrates
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2023 |
Main clinical characteristics and evolutionary events among patients suffering Wilson disease in Spain: first results from the Spanish Wilson registry
|
JOURNAL OF HEPATOLOGY |
Artículo | 2023 |
Neuroblastoma RAS viral oncogene homolog (N-RAS) deficiency aggravates liver injury and fibrosis
|
CELL DEATH & DISEASE |
Resumen congreso | 2023 |
NOVEL ARTIFICIAL INTELLIGENCE-ASSISTED DIGITAL PATHOLOGY QUANTITATIVE IMAGE ANALYSIS PREDICTS THE OCCURRENCE OF LIVER-RELATED CLINICAL EVENTS IN THE MULTICENTRIC, EUROPEAN, HEPATIC OUTCOMES AND SURVIVAL FATTY LIVER REGISTRY (HOTSURFR) STUDY
|
HEPATOLOGY |
Resumen congreso | 2023 |
Novel artificial intelligence-assisted digital pathology quantitative image analysis predicts the occurrence of liver-related clinical events in the multicentric, European, hepatic outcomes and survival fatty liver registry (HOTSURFR) study
|
JOURNAL OF HEPATOLOGY |
Artículo | 2023 |
Predicting liver-related events in NAFLD: A predictive model
|
HEPATOLOGY |
Resumen congreso | 2023 |
PREDICTION OF BIOCHEMICAL RESPONSE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS TREATED WITH OBETICHOLIC ACID: DERIVATION AND EXTERNAL VALIDATION OF THE OCA RESPONSE SCORE (ORS)
|
HEPATOLOGY |
Editorial | 2023 |
Prognostication in Advanced Chronic Liver Disease Using Liver Stiffness Measurement: Repetita Iuvant
|
GASTROENTEROLOGY |
Artículo | 2023 |
Reingresos hospitalarios en pacientes cirróticos: un desafío en el horizonte
|
Revista Andaluza de Patología Digestiva |
Resumen congreso | 2023 |
Risk of decompensated cirrhosis in patients with primary biliary cholangitis under first, second and third-line therapies
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2023 |
Rivaroxaban improves survival and decompensation in cirrhotic patients with moderate liver dysfunction. Double-blind, placebocontrolled trial
|
JOURNAL OF HEPATOLOGY |
Artículo | 2023 |
Role of EpCAM+ CD133+ extracellular vesicles in steatosis to steatohepatitis transition in NAFLD.
|
LIVER INTERNATIONAL |
Artículo | 2023 |
Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplant
|
HEPATOLOGY COMMUNICATIONS |
Resumen congreso | 2023 |
Single-cell RNA sequencing in DIAMOND mice reveals differentially regulated pathways specifically associated with the transition from simple steatosis towards NASH
|
JOURNAL OF HEPATOLOGY |
Resumen congreso | 2023 |
The combination of LACE index, MELDon discharge and a previous history of decompensation defines risk groups for early readmission in patients with liver cirrhosis
|
JOURNAL OF HEPATOLOGY |
Revisión | 2023 |
The essential role of IL-17 as the pathogenetic link between psoriasis and metabolic-associated fatty liver disease
|
Life |
Resumen congreso | 2023 |
Variation in the presentation pattern of primary biliary cholangitis (PBC) in Spain according to the diagnostic period: data from the Spanish registry of cholestatic and autoimmune liver diseases (COLHAI)
|
JOURNAL OF HEPATOLOGY |
Artículo | 2022 |
A 2-step strategy combining FIB-4 with transient elastography and ultrasound predicted liver cancer after HCV cure
|
AMERICAN JOURNAL OF GASTROENTEROLOGY |
Artículo | 2022 |
A shortcut from metabolic-associated fatty liver disease (MAFLD) to hepatocellular carcinoma (HCC): c-MYC a promising target for preventative strategies and individualized therapy
|
CANCERS |
Resumen congreso | 2022 |
Approaches for a hepatitis C-free city: preliminary results
|
JOURNAL OF HEPATOLOGY |
Artículo | 2022 |
Bone morphogenetic protein 2 is a new molecular target linked to non-alcoholic fatty liver disease with potential value as non-invasive screening tool
|
Biomarker Research |
Artículo | 2022 |
Cardiometabolic characterization in metabolic dysfunction–associated fatty liver disease
|
FRONTIERS IN MEDICINE |
Artículo | 2022 |
Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?
|
GUT |
Artículo | 2022 |
Co-12. Eficacia y seguridad de las prótesis de aposición luminal en el drenaje ecoendoscópico de colecciones abdominales y la influencia del catéter pigtail coaxial en la tasa de complicaciones y de revisiones endoscópicas.
|
Revista Andaluza de Patología Digestiva |
Resumen congreso | 2022 |
Confounding factors in diagnostic performance of magnetic resonance elastography for staging liver fibrosis in patients with non-alcoholic fatty liver disease: an individual patient data meta-analysis
|
JOURNAL OF HEPATOLOGY |
Revisión | 2022 |
Contribution of liver and pancreatic islet crosstalk to β-cell function/dysfunction in the presence of fatty liver
|
Frontiers in Endocrinology |
Corrección | 2022 |
Correction to: A 2-step strategy combining FIB-4 with transient elastography and ultrasound predicted liver cancer after HCV cure
|
AMERICAN JOURNAL OF GASTROENTEROLOGY |
Artículo | 2022 |
Derivation and validation of the NAFLD Cirrhosis Score (NCS) to distinguish bridging fibrosis from cirrhosis
|
EUROPEAN JOURNAL OF INTERNAL MEDICINE |
Resumen congreso | 2022 |
Diagnostic accuracy of MRE for staging hepatic fibrosis in patients with NAFLD
|
JOURNAL OF HEPATOLOGY |
Artículo | 2022 |
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis
|
GUT |
Resumen congreso | 2022 |
Dysregulation of the urea cycle enzymes determines a more severe NAFLD phenotype in a DIAMOND preclinical model
|
JOURNAL OF HEPATOLOGY |
Revisión | 2022 |
Emerging pharmacological treatment options for MAFLD
|
Therapeutic Advances in Endocrinology and Metabolism |
Resumen congreso | 2022 |
EpCAM+CD133+Microvesicles: novel biomarker in NAFLD
|
HEPATOLOGY |
Artículo | 2022 |
Extracellular Vesicles as Biomarkers in Liver Disease
|
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
Revisión | 2022 |
General overview about the current management of nonalcoholic fatty liver disease
|
CLINICAL DRUG INVESTIGATION |
Resumen congreso | 2022 |
Glutaminolysis and steatosis to steatohepatitis transition: role of glutaminase
|
HEPATOLOGY |
Artículo | 2022 |
Glutaminolysis-ammonia-urea Cycle Axis, Non-alcoholic Fatty Liver Disease Progression and Development of Novel Therapies.
|
Journal of Clinical and Translational Hepatology |
Resumen congreso | 2022 |
Identification of new potential biomarkers to follow steatohepatitis in patients with non-alcoholic/metabolic-associated fatty liver disease
|
JOURNAL OF HEPATOLOGY |
Artículo | 2022 |
Impact of a Loss-of-Function Variant in HSD17B13 on Hepatic Decompensation and Mortality in Cirrhotic Patients
|
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
Resumen congreso | 2022 |
Impact of genes related to metabolic associated fatty liver disease (MAFLD) in response to hypocaloric dietary intervention: nutrigenomic analysis
|
HEPATOLOGY |
Artículo | 2022 |
Inhibition of ATG3 ameliorates liver steatosis by increasing mitochondrial function
|
JOURNAL OF HEPATOLOGY |
Artículo | 2022 |
Liver injury in non-alcoholic fatty liver disease is associated with urea cycle enzyme dysregulation
|
Scientific reports |
Artículo | 2022 |
Liver-related and extrahepatic events in patients with non-alcoholic fatty liver disease: a retrospective competing risks analysis.
|
ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
Artículo | 2022 |
Long non-coding RNA H19 as a biomarker for hepatocellular carcinoma
|
LIVER INTERNATIONAL |
Revisión | 2022 |
Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH)
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Artículo | 2022 |
Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events
|
JOURNAL OF HEPATOLOGY |
Artículo | 2022 |
Plasma ammonia levels predict hospitalisation with liver-related complications and mortality in clinically stable outpatients with cirrhosis
|
JOURNAL OF HEPATOLOGY |
Artículo | 2022 |
Prevalence estimation of significant fibrosis because of NASH in Spain combining transient elastography and histology
|
LIVER INTERNATIONAL |
Artículo | 2022 |
Prevalence of non-alcoholic fatty liver disease (NAFLD) in a cohort of patients with type 2 diabetes: the PHIGNA-DM2 study
|
NUTRICION HOSPITALARIA |
Letter | 2022 |
Primary biliary cholangitis and SARS-CoV-2 infection: incidence, susceptibility and outcomes
|
GUT |
Resumen congreso | 2022 |
Safety and effectiveness of vaccines agains SARS-COV-2 in patients with liver cancer. VacHep registry: response analysis 4 weeks after the second dose.
|
JOURNAL OF HEPATOLOGY |
Artículo | 2022 |
Systematic review and meta-analysis: analysis of variables influencing the interpretation of clinical trial results in NAFLD
|
Journal of Gastroenterology |
Artículo | 2021 |
Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality.
|
JOURNAL OF CLINICAL INVESTIGATION |
Artículo | 2021 |
An experimental DUAL model of advanced liver damage
|
HEPATOLOGY COMMUNICATIONS |
Revisión | 2021 |
Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases
|
FRONTIERS IN IMMUNOLOGY |
Resumen congreso | 2021 |
Circulating PCSK9 levels are correlated with advanced disease in patients with biopsy-proven non-alcoholic fatty liver disease.
|
ATHEROSCLEROSIS |
Artículo | 2021 |
Clinical characteristics and outcome of drug-induced liver injury in the older patients: from the young-old to the oldest-old
|
CLINICAL PHARMACOLOGY & THERAPEUTICS |
Artículo | 2021 |
CO-03. Impacto del tratamiento antiviral con tenofovir para la hepatitis crónica b en la incidencia de infección sars-cov-2 y covid-19. Estudio multicéntrico covhb
|
Revista Andaluza de Patología Digestiva |
Artículo | 2021 |
CO-14. Evaluación de la capacidad diagnóstica de fibrosis y cuantificación de esteatosis hepática mediante rm en pacientes con esteatosis hepática metabólica (ehmet)
|
Revista Andaluza de Patología Digestiva |
Artículo | 2021 |
CO-16. Colangitis biliar primaria e infección por sars-cov-2: Incidencia, susceptibilidad y resultados
|
Revista Andaluza de Patología Digestiva |
Artículo | 2021 |
Combination of squamous cell carcinoma antigen immunocomplex and alpha-fetoprotein in mid- And long-term prediction of hepatocellular carcinoma among cirrhotic patients
|
WORLD JOURNAL OF GASTROENTEROLOGY |
Artículo | 2021 |
Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry
|
JOURNAL OF HEPATOLOGY |
Letter | 2021 |
COVID-19 and the liver: the chicken or the egg dilemma
|
Revista Española de Enfermedades Digestivas |
Artículo | 2021 |
Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: a longitudinal study of 1893 biopsy-proven nonalcoholic fatty liver disease subjects
|
LIVER INTERNATIONAL |
Artículo | 2021 |
Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection
|
CELLULAR & MOLECULAR IMMUNOLOGY |
Artículo | 2021 |
Development and validation of a clinical-genetic risk score to predict hepatic encephalopathy in patients with liver cirrhosis.
|
AMERICAN JOURNAL OF GASTROENTEROLOGY |
Artículo | 2021 |
Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis
|
JOURNAL OF HEPATOLOGY |
Artículo | 2021 |
Effectiveness and safety of obeticholic acid in a Southern European multicenter cohort of patients with primary biliary cholangitis and suboptimal response to ursodeoxycholic acid
|
ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
Resumen congreso | 2021 |
Impact of a loss-of-function variant in HSD17B13 on hepatic decompensation and mortality in cirrhotic patients
|
JOURNAL OF HEPATOLOGY |
Artículo | 2021 |
Impact of COVID-19 on liver disease: From the experimental to the clinic perspective.
|
World journal of virology |
Artículo | 2021 |
Impact of liver injury on the severity of COVID-19: a systematic review with meta-analysis
|
Revista Española de Enfermedades Digestivas |
Artículo | 2021 |
Interrelación entre esteatosis hepática metabólica y diabetes mellitus e hipertensión arterial
|
REVISTA DE NUTRICION PRACTICA |
Artículo | 2021 |
Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease.
|
JOURNAL OF HEPATOLOGY |
Artículo | 2021 |
Management of NAFLD patients with advanced fibrosis
|
LIVER INTERNATIONAL |
Artículo | 2021 |
Mapping the human genetic architecture of COVID-19.
|
NATURE |
Artículo | 2021 |
Monitoring occurrence of liver-related events and survival by transient elastography in patients with nonalcoholic fatty liver disease and compensated advanced chronic liver disease
|
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
Artículo | 2021 |
Precisión diagnóstica y limitaciones de los test no invasivos en pacientes con esteatosis hepática metabólica
|
Revista Andaluza de Patología Digestiva |
Editorial | 2021 |
Propuesta de nueva denominación: esteatosis hepática metabólica (EHmet)
|
Revista Española de Enfermedades Digestivas |
Letter | 2021 |
Reply to: “The predictive value of significant fibrosis for metabolic disturbances in patients with NAFLD”
|
JOURNAL OF HEPATOLOGY |
Artículo | 2021 |
SARS-CoV-2 viral load in nasopharyngeal swabs is not an independent predictor of unfavorable outcome
|
Scientific reports |
Artículo | 2021 |
Simple non-invasive scoring systems and histologic scores in predicting mortality in NAFLD patients: a systematic review and meta-analysis
|
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
Letter | 2021 |
Sofosbuvir improves HCV-induced insulin resistance by blocking IRS1 degradation
|
Clinical and translational medicine |
Revisión | 2021 |
Wilson's disease: revisiting an old friend
|
World Journal of Hepatology |
Artículo | 2020 |
Bacterial antigen translocation and age as BMI-independent contributing factors on systemic inflammation in NAFLD patients
|
LIVER INTERNATIONAL |
Artículo | 2020 |
Co-12. Análisis de factores que afectan la seguridad diagnóstica de la elastografía por resonancia magnética (erm) en pacientes con mafld.
|
Revista Andaluza de Patología Digestiva |
Artículo | 2020 |
Co-17. Determinación de micropartículas apoptóticas de origen hepático en pacientes con enfermedad hepática metabólica grasa
|
Revista Andaluza de Patología Digestiva |
Revisión | 2020 |
COVID-19 and the digestive system: protection and management during the SARS-CoV-2 pandemic
|
Revista Española de Enfermedades Digestivas |
Artículo | 2020 |
Development and Validation of Hepamet Fibrosis Scoring System–A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis
|
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
Corrección | 2020 |
Erratum to: “Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH
|
JOURNAL OF HEPATOLOGY |
Artículo | 2020 |
Hepatitis C virus clearance by direct-acting antivirals agents improves endothelial dysfunction and subclinical atherosclerosis: HEPCAR study
|
Clinical and translational gastroenterology |
Artículo | 2020 |
Manejo de la enfermedad hepática metabólica grasa
|
Revista Andaluza de Patología Digestiva |
Capítulo | 2020 |
Morbid obesity and hepatitis C: treat as normal or are there additional issues to consider?
|
Clinical Dilemmas in Viral Liver Disease, Second Edition |
Artículo | 2020 |
Nonalcoholic fatty liver disease and the risk of metabolic comorbidities: how to manage in clinical practice
|
Polish archives of internal medicine |
Artículo | 2020 |
Oral glutamine challenge is a marker of altered ammonia metabolism and predicts the risk of hepatic encephalopathy
|
LIVER INTERNATIONAL |
Editorial | 2020 |
Reflex testing. A key tool for the elimination of hepatitis C
|
Revista Española de Enfermedades Digestivas |
Artículo | 2020 |
Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH
|
JOURNAL OF HEPATOLOGY |
Artículo | 2020 |
Stratification of patients in NASH clinical trials: a pitfall for trial success
|
JHEP Reports |
Capítulo | 2020 |
The spectrum of NAFLD: From the organ to the system
|
NAFLD and NASH: biomarkers in detection, diagnosis and monitoring |
Artículo | 2019 |
Analysis of the burden and variability in the management of NAFLD patients in the clinical practice: unifying the required criteria
|
Revista Española de Enfermedades Digestivas |
Artículo | 2019 |
Co-27. Índice de fibrosis hepática: Estratificación del riesgo de enfermedad hepática metabólica grasa en atención primaria.
|
Revista Andaluza de Patología Digestiva |
Resumen congreso | 2019 |
Droplet digital pcr analysis of circulating lncrna h19: a potential biomarker for hepatocellular carcinoma
|
HEPATOLOGY |
Artículo | 2019 |
Higher levels of serum uric acid influences hepatic damage in patients with non-alcoholic fatty liver disease (NAFLD)
|
Revista Española de Enfermedades Digestivas |
Artículo | 2019 |
Metabolic characterization of two different non-alcoholic fatty liver disease pre-clinical mouse models
|
Revista Española de Enfermedades Digestivas |
Artículo | 2019 |
Quality of life in patients with hepatitis C. Importance of treatment
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Resumen congreso | 2019 |
Sesión IV.: Búsqueda de biomarcadores en la enfermedad hepática metabólica grasa: aproximación transcriptómica
|
Revista Andaluza de Patología Digestiva |
Artículo | 2019 |
Sofosbuvir/velpatasvir for 12 weeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysis
|
JOURNAL OF HEPATOLOGY |
Artículo | 2019 |
Usefulness of bioelectrical impedance analysis for monitoring patients with refractory ascites
|
Revista Española de Enfermedades Digestivas |
Artículo | 2018 |
Co-12. Determinantes genéticos de encefalopatía hepática en pacientes con cirrosis: Análisis de genes candidatos
|
Revista Andaluza de Patología Digestiva |
Resumen congreso | 2018 |
Co-13. Disminución de micropartículas apoptóticas endoteliales y plaquetarias en pacientes con hepatitis c tras el tratamiento con aad
|
Revista Andaluza de Patología Digestiva |
Resumen congreso | 2018 |
Co-20. Mejora de la función endotelial en pacientes con virus c tras el tratamiento con aad
|
Revista Andaluza de Patología Digestiva |
Resumen congreso | 2018 |
Co-21. Uso de microarns como biomarcadores no invasivos en enfermedad hepática metabólica por depósito de grasa no alcohólica
|
Revista Andaluza de Patología Digestiva |
Artículo | 2018 |
Co-28. Carga y variabilidad en el manejo de pacientes con ehgna en la práctica clínica: Hacia criterios unificados
|
Revista Andaluza de Patología Digestiva |
Resumen congreso | 2018 |
Co-29. Investigación traslacional en ehgna: Estudio genético y funcional de fgf-21
|
Revista Andaluza de Patología Digestiva |
Artículo | 2018 |
Diagnostic accuracy of SCCA and SCCA-IgM for hepatocellular carcinoma: A meta-analysis
|
LIVER INTERNATIONAL |
Artículo | 2018 |
Duration of the acute hepatic encephalopathy episode determines survival in cirrhotic patients
|
Therapeutic Advances in Gastroenterology |
Editorial | 2018 |
Editorial: looking for patients at risk of cirrhosis in the general population-many needles in a haystack
|
ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
Artículo | 2018 |
Herbal and Dietary Supplement-Induced Liver Injuries in the Spanish DILI Registry
|
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
Artículo | 2018 |
Impact of comorbidities on patient outcomes after interferon-free therapy-induced viral eradication in hepatitis C
|
JOURNAL OF HEPATOLOGY |
Artículo | 2018 |
Metformin modifies glutamine metabolism in an in vitro and in vivo model of hepatic encephalopathy
|
Revista Española de Enfermedades Digestivas |
Artículo | 2018 |
Minimal hepatic encephalopathy identifies patients at risk of faster cirrhosis progression
|
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
Revisión | 2018 |
miRNAs in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis
|
JOURNAL OF HEPATOLOGY |
Revisión | 2018 |
Nuevas perspectivas terapéuticas en la esteatohepatitis no alcohólica
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Artículo | 2018 |
Peer-to-Peer Sessions in Primary Care to Improve the Hepatitis B Detection Rate in Seville, Spain
|
ANNALS OF HEPATOLOGY |
Resumen congreso | 2018 |
Role of the Long Non-Coding RNA H19 in the Context of Hepatocellular Carcinoma
|
HEPATOLOGY |
Artículo | 2018 |
Simvastatin and metformin inhibit cell growth in hepatitis C virus infected cells via mTOR increasing PTEN and autophagy
|
PLOS ONE |
Editorial | 2018 |
Solving doubts about L-ornithine L-aspartate for overt hepatic encephalopathy: Whom and how to treat
|
HEPATOLOGY |
Artículo | 2018 |
The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesity
|
ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
Revisión | 2018 |
The impact of minimal hepatic encephalopathy treatment in long-term prognosis
|
Salud(i)Ciencia |
Editorial | 2017 |
Acute-on-chronic liver failure: a time to step forward
|
Revista Española de Enfermedades Digestivas |
Revisión | 2017 |
Cardiovascular assessment in liver transplant for nonalcoholic steatohepatitis patients: What we do, what we should do
|
World Journal of Hepatology |
Artículo | 2017 |
Co-11. La frecuencia crítica de parpadeo mejora su rendimiento diagnóstico y predictivo de encefalopatía hepática al incorporar la desviación estándar como criterio de calidad
|
Revista Andaluza de Patología Digestiva |
Artículo | 2017 |
Co-12. Papel del factor de crecimiento de fibroblasto 21 (fgf21) en pacientes con eghna: Estudio genético y funcional
|
Revista Andaluza de Patología Digestiva |
Artículo | 2017 |
Co-19. Estudio del perfil epigenético en una cohorte de pacientes con hepatitis crónica c: Cirróticos versus hepatocarcinoma
|
Revista Andaluza de Patología Digestiva |
Artículo | 2017 |
Co-20. Validación de los índices fib 4 y nfs para discriminar fibrosis hepática en pacientes con eghna en práctica clínica habitual.
|
Revista Andaluza de Patología Digestiva |
Artículo | 2017 |
Effectiveness and safety of sofosbuvir-based regimens plus an NS5A inhibitor for patients with HCV genotype 3 infection and cirrhosis. Results of a multicenter real-life cohort
|
JOURNAL OF VIRAL HEPATITIS |
Artículo | 2017 |
Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort
|
JOURNAL OF HEPATOLOGY |
Artículo | 2017 |
Lactulose reduces bacterial DNA translocation, which worsens neurocognitive shape in cirrhotic patients with minimal hepatic encephalopathy
|
LIVER INTERNATIONAL |
Artículo | 2017 |
Real-World Effectiveness and Safety of Oral Combination Antiviral Therapy for Hepatitis C Virus Genotype 4 Infection
|
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
Revisión | 2016 |
Case Report: Acute-on-Chronic Liver Failure: Making the Diagnosis between Infection and Acute Alcoholic Hepatitis
|
SEMINARS IN LIVER DISEASE |
Artículo | 2016 |
FibroGENE: A gene-based model for staging liver fibrosis
|
JOURNAL OF HEPATOLOGY |
Artículo | 2016 |
Hepatitis C virus genotype 3: Meta-analysis on sustained virologic response rates with currently available treatment options
|
WORLD JOURNAL OF GASTROENTEROLOGY |
Artículo | 2016 |
Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease
|
Scientific reports |
Artículo | 2016 |
Low phase angle is associated with the development of hepatic encephalopathy in patients with cirrhosis
|
WORLD JOURNAL OF GASTROENTEROLOGY |
Artículo | 2016 |
New technologies - new insights into the pathogenesis of hepatic encephalopathy
|
METABOLIC BRAIN DISEASE |
Artículo | 2016 |
Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients
|
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
Revisión | 2016 |
Pharmacogenetics of ribavirin-induced anemia in hepatitis C
|
PHARMACOGENOMICS |
Artículo | 2016 |
Remission maintained by monotherapy after biological plus immunosuppressive combination for Crohn's disease in clinical practice
|
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
Revisión | 2016 |
Role of assessing liver fibrosis in management of chronic hepatitis C virus infection
|
CLINICAL MICROBIOLOGY AND INFECTION |
Artículo | 2016 |
Sedación endoscópica en la cirrosis hepática
|
Revista Andaluza de Patología Digestiva |
Ponencia | 2016 |
Validación preliminar de la aplicación Cliente/Servidor del software DeMILI para el diagnóstico de enfermedades del hígado
|
CASEIB 2016 XXXIV Congreso Anual de la Sociedad Española de Ingeniería Biomédica: Libro de actas |
Artículo | 2015 |
2. Continuidad asistencial de la hepatitis c desde la deteccion al tratamiento: Impacto de las sesiones formativas en atencion primaria.
|
Revista Andaluza de Patología Digestiva |
Artículo | 2015 |
28. Impacto de la medición objetiva de comorbilidades en el beneficio de la terapia antiviral libre de interferón en hepatitis C
|
Revista Andaluza de Patología Digestiva |
Revisión | 2015 |
Assessing cardiovascular risk in hepatitis C: An unmet need
|
World Journal of Hepatology |
Artículo | 2015 |
Association of NAFLD with subclinical atherosclerosis and coronary-artery disease: Meta-analysis
|
Revista Española de Enfermedades Digestivas |
Artículo | 2015 |
Fine-mapping butyrophilin family genes revealed several polymorphisms influencing viral genotype selection in hepatitis C infection
|
Genes & Immunity |
Artículo | 2015 |
Hepatitis C Virus Current and Evolving Treatments for Genotypes 2 and 3
|
GASTROENTEROLOGY CLINICS OF NORTH AMERICA |
Artículo | 2015 |
Minimal Hepatic Encephalopathy and Critical Flicker Frequency Are Associated With Survival of Patients With Cirrhosis
|
GASTROENTEROLOGY |
Artículo | 2015 |
Prediction of Week 4 Virological Response in Hepatitis C for Making Decision on Triple Therapy: The Optim Study
|
PLOS ONE |
Revisión | 2015 |
Prevention of hepatocellular carcinoma by correction of metabolic abnormalities: Role of statins and metformin
|
World Journal of Hepatology |
Artículo | 2015 |
Role of ITPA and SLC28A2 genes in the prediction of anaemia associated with protease inhibitor plus ribavirin and peginterferon in hepatitis C treatment
|
JOURNAL OF CLINICAL VIROLOGY |
Capítulo | 2015 |
The oral glutamine challenge in liver cirrhosis
|
Glutamine in Clinical Nutrition |
Letter | 2015 |
Trombosis portal: más allá de la cirrosis hepática
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Editorial | 2014 |
Deciphering the Spectrum of Low-Grade Hepatic Encephalopathy in Clinical Practice
|
GASTROENTEROLOGY |
Revisión | 2014 |
HCV genotype 3 - the new treatment challenge
|
ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
Artículo | 2014 |
Hepatotoxicidad inducida por estanozolol
|
Revista Andaluza de Patología Digestiva |
Letter | 2014 |
Hypoxic hepatitis as diabetic ketoacidosis complication
|
Revista Española de Enfermedades Digestivas |
Artículo | 2014 |
PNPLA3 rs738409 causes steatosis according to viral & IL28B genotypes in hepatitis C
|
ANNALS OF HEPATOLOGY |
Artículo | 2014 |
Polycystic liver in the adult (PLA) in Spain: Analysis of a structured survey analysing the experience and attitude of Spanish gastroenterologists
|
Revista Española de Enfermedades Digestivas |
Artículo | 2014 |
Predictive factors for erythema nodosum and pyoderma gangrenosum in inflammatory bowel disease
|
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
Artículo | 2014 |
Síndrome LPAC secundario a deleción del exón 4 del gen ABCB4 en un paciente con hepatitis C
|
Revista Española de Enfermedades Digestivas |
Editorial | 2014 |
Stanozolol-induced bland cholestasis
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Letter | 2014 |
Tetany and convulsions: Onset symptoms in crohn’s disease
|
Revista Española de Enfermedades Digestivas |
Artículo | 2013 |
Esteatohepatitis alcohólica y no alcohólica: ¿quiénes son los pacientes y qué podemos hacer por ellos?
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Revisión | 2013 |
Hepatobiliary manifestations in inflammatory bowel disease: The gut, the drugs and the liver
|
WORLD JOURNAL OF GASTROENTEROLOGY |
Resumen congreso | 2013 |
I148M PNPLA3 variant promotes steatosis according to viral and IL28B genotype but does not affect sustained viral response in patients with hepatitis C
|
JOURNAL OF HEPATOLOGY |
Artículo | 2013 |
Impacto de la realización de sesiones formativas en la detección de la hepatitis b y c en atención primaria (ver tabla)
|
Revista Andaluza de Patología Digestiva |
Artículo | 2013 |
Insulin resistance predicts sustained virological response to treatment of chronic hepatitis C independently of the IL28b rs12979860 polymorphism
|
ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
Ponencia | 2013 |
KLF12 polymorphism improves ITPA predictability of anemia in hepatitis C treated with peginterferon plus ribavirin
|
HEPATOLOGY |
Resumen congreso | 2013 |
KLF12 polymorphism rs9543524 predicts anemia in patients with chronic hepatitis C treated with peginterferon and ribavirin
|
JOURNAL OF HEPATOLOGY |
Artículo | 2013 |
Las variantes de pnpla3 promueven la esteatosis en función del genotipo viral y la ilb28 sin afectar a la respuesta viral sostenida en pacientes con hepatitis C
|
Revista Andaluza de Patología Digestiva |
Artículo | 2013 |
Meta-analysis: pegylated interferon α-2a achieves higher early virological responses than α-2b in chronic hepatitis C
|
ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
Ponencia | 2013 |
Metformin reduces plasmatic ammonia in portacaval shunted rats
|
HEPATOLOGY |
Artículo | 2013 |
Metformina reduce los niveles de amonio plástico en ratas con derivación portocava
|
Revista Andaluza de Patología Digestiva |
Letter | 2013 |
Mielotoxicidad por la interacción entre azatioprina y alopurinol en paciente con enfermedad de Crohn
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Resumen congreso | 2013 |
Non-alcoholic steatohepatitis increases the production of antibodies against oxidized LDL, atherosclerosis and cardiovascular risk
|
JOURNAL OF HEPATOLOGY |
Artículo | 2013 |
Predicting portal hypertension and variceal bleeding using non-invasive measurements of metabolic variables
|
ANNALS OF HEPATOLOGY |
Artículo | 2013 |
Role of diabetes mellitus on hepatic encephalopathy
|
METABOLIC BRAIN DISEASE |
Resumen congreso | 2013 |
Validation study of the impact of SNPs from GWAS associated with fibrosis progression in chronic hepatitis C (HCV)
|
HEPATOLOGY |
Artículo | 2012 |
5. Recidiva tras el cambio de la doble terapia a la monoterapia en la enfermedad de Crohn
|
Revista Andaluza de Patología Digestiva |
Artículo | 2012 |
Influencia de la enfermedad hepática por hígado graso no alcohólico sobre la enfermedad cardiovascular: Metaanálisis
|
Revista Andaluza de Patología Digestiva |
Artículo | 2012 |
Influencia de la enfermedad por hígado graso no alcohólico en la enfermedad cardiovascular
|
GASTROENTEROLOGIA Y HEPATOLOGIA |
Artículo | 2012 |
Interacción entre los genotipos virales y del hospedador influenciados por la infección del virus de la hepatitis C
|
Revista Andaluza de Patología Digestiva |
Artículo | 2012 |
Metformin Inhibits Glutaminase Activity and Protects against Hepatic Encephalopathy
|
PLOS ONE |
Ponencia | 2012 |
Non-alcoholic fatty liver disease (NAFLD) influences on cardiovascular disease: Meta-analysis
|
HEPATOLOGY |
Artículo | 2012 |
Pancreatitis aguda e infección por Salmonella Enteritidis
|
Revista Andaluza de Patología Digestiva |
Ponencia | 2012 |
PNPLA3 and DISC1 are associated with steatosis in patients with chronic hepatitis C
|
HEPATOLOGY |
Letter | 2012 |
Unsedated colonoscopy: an option for some but not for all
|
GASTROINTESTINAL ENDOSCOPY |